Valuation: VisionSys AI Inc.

Market Cap 54.21M 8.08M 6.96M 6.59M 5.98M 11.21M 772M 11.27M 78.3M 30.11M 393M 30.35M 29.68M 1.24B P/E 2024
-0.09x
P/E 2025 0.01x
Enterprise Value 766K 114K 98.37K 93.14K 84.42K 158K 10.91M 159K 1.11M 425K 5.55M 429K 419K 17.53M EV / Sales 2024
0.22x
EV / Sales 2025 -34.3x
Free-Float
13.24%
Yield 2024 *
-
Yield 2025 -
1 day-3.33%
1 week-11.59%
Current month-12.39%
1 month-21.62%
3 months-36.68%
6 months-65.27%
Current year-88.07%
1 week 2.9
Extreme 2.9
3.23
1 month 2.9
Extreme 2.9
3.74
Current year 2.76
Extreme 2.76
33.65
1 year 2.76
Extreme 2.76
2,120.35
3 years 2.76
Extreme 2.76
2,120.35
5 years 2.76
Extreme 2.76
4,125
10 years 2.76
Extreme 2.76
54,250
Manager TitleAgeSince
Chief Executive Officer 40 04/12/2025
Director of Finance/CFO - 04/12/2025
Chief Executive Officer 50 07/04/2021
Director TitleAgeSince
Director/Board Member 61 31/03/2014
Director/Board Member 62 30/11/2022
Director/Board Member - 04/12/2025
Change 5-day change 1-year change 3-year change Capi.($)
-3.33%-11.59%-99.86%-99.73% 8.08M
+1.51%-3.75%-1.39%+10.28% 45.48B
+0.21%-2.98%+337.74%+520.30% 43.68B
+1.74%-2.24%+39.82%+20.85% 43.09B
+1.38%-3.28%+6.84%+73.19% 39.4B
-1.44%-5.26%+8.97%+39.76% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+19.75%+108.58% 16.4B
+2.77%+1.48%+15.19%+31.82% 14.24B
+1.93%-3.55%+82.00%+36.66% 13.28B
Average +0.64%-4.04%+45.45%+82.41% 26.48B
Weighted average by Cap. +0.96%-3.50%+75.11%+125.11%

Financials

2024 2025
Net sales 1.17B 175M 150M 142M 129M 242M 16.67B 243M 1.69B 650M 8.48B 655M 641M 26.8B 1.04M 155K 133K 126K 115K 215K 14.8M 216K 1.5M 577K 7.53M 582K 569K 23.79M
Net income -587M -87.43M -75.33M -71.33M -64.65M -121M -8.35B -122M -847M -326M -4.25B -328M -321M -13.43B 1.72B 256M 221M 209M 189M 355M 24.48B 357M 2.48B 955M 12.45B 962M 941M 39.35B
Net Debt 208M 30.99M 26.7M 25.28M 22.92M 42.99M 2.96B 43.21M 300M 115M 1.51B 116M 114M 4.76B -53.44M -7.97M -6.86M -6.5M -5.89M -11.05M -761M -11.11M -77.19M -29.68M -387M -29.92M -29.26M -1.22B
Logo VisionSys AI Inc.
VisionSys AI Inc is a holding company primarily engaged in the development of brain-computer interface (BCI) technologies and related businesses. The Company's main business is developing, procuring, selling, and distributing BCI-enabled or BCI-adjacent products and solutions, and to provide related technical services. The BCI technologies are used in medical and healthcare-related applications, including functional rehabilitation, communication support, neurological disease-related monitoring and intervention, sensory assistance, and general wellness management. The Company mainly operates its businesses in the domestic market.
Employees
17
Date Price Change Volume
11/09/26 US$2.900 -3.33% 4,174
10/09/26 US$3.000 0.00% 2,667
09/09/26 US$3.000 -0.33% 6,578
08/09/26 US$3.010 -8.23% 14,397
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!